General Information
Product name
Fenofibrate Tablets USP, 48 mg & 145 mg
Manufacturer Name
Hetero Labs Limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc
Section 2
SECTION 2: Hazards identification
Fire and Explosion Expected to be non-combustible. Health Fenofibrate is contraindicated in patients who exhibit hypersensitivity to fenofibrate. Fenofibrate is contraindicated in patients with hepatic or severe renal dysfunction, including primary biliary cirrhosis, and patients with unexplained persistent liver function abnormality. Fenofibrate is contraindicated in patients with preexisting gallbladder disease
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.
